Precision post-translational modification of PML defines neuroblastoma clinical behaviour
{{output}}
Background: Promyelocytic leukaemia protein (PML), a key regulator of nuclear architecture and cellular homeostasis, is increasingly recognised for its tumour-suppressive functions. In neuroblastoma (NBL), a clinically heterogene... ...
